Neil F. McFarlane
President and CEO, Director · ZEVRA THERAPEUTICS, INC.
- 2025
- Oct 13, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil F. McFarlane files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rahsaan Thompson - $969K in ZVRA purchases and sales in the last 12 months
- Corey Michael Watton - $138K in ZVRA purchases and sales in the last 12 months
- Joshua Schafer - $126K in ZVRA purchases and sales in the last 12 months
- Timothy J. Sangiovanni - $43K in ZVRA purchases and sales in the last 12 months
- Adrian W. Quartel - $40K in ZVRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil F. McFarlane?
Neil F. McFarlane is a corporate insider, tracked as President and CEO, Director of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Neil F. McFarlane submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Neil F. McFarlane been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.41M) across all tracked filings.
